Naproxen Sodium
Product Images NDC 62207-750

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium (NDC 62207-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\administrator\desktop\spl Sci\spl2\nap-sod Capsule-shaped-tablets.jpg (Fea7ea82 Figure 01)

Drug Facts panel for Naproxen Sodium Tablets USP 220 mg by Granules India Limited. The label includes strength, active ingredient information, uses, warnings, directions, other information like inactive ingredients and storage, questions or comments contact, manufacturer details, and expiration and lot number fields.*

FDA Label Image

C:\users\administrator\desktop\spl Sci\spl2\nap-sod Tablets.jpg (Fea7ea82 Figure 02)

Drug Facts panel for Naproxen Sodium Tablets USP 220 mg by Granules India Limited. The text outlines active ingredients, purposes, uses, warnings (including allergy and stomach bleeding alerts), when to consult a doctor, dosage directions, other information about tablet contents and storage, inactive ingredients, as well as contact information and manufacturing details. The panel also includes precautions for pregnant or breastfeeding women and children under 12 years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.